Menu
IBM's new US$1B acquisition will help Watson 'see'

IBM's new US$1B acquisition will help Watson 'see'

The addition of Merge's imaging data could advance personalized medicine, IBM says

IBM expects its acquisition of Merge Healthcare to give Watson the ability to "see."

IBM expects its acquisition of Merge Healthcare to give Watson the ability to "see."

IBM plans to buy Merge Healthcare in a US$1 billion deal that promises to bring new image-focused capabilities to its Watson Health platform.

Under the terms of the acquisition, which was announced Thursday and is expected to close later this year, Merge shareholders will receive $7.13 per share in cash. The deal is IBM's third and largest major health-related acquisition since it launched its Watson Health unit in April.

Merge's technology provides medical image handling and processing and is currently used at more than 7,500 U.S. health care sites. IBM plans to use its Watson Health Cloud to analyze and cross-reference Merge's medical images against lab results, electronic health records, genomic tests, clinical studies and other health-related data sources amounting to 315 billion data points and 90 million unique records.

In effect, IBM believes the combination of the two firms will help advance its Watson cognitive computing system beyond natural language and give it the ability to "see." The goal, it said, is to shed new light on current and historical images, electronic health records and data from wearable devices.

Armed with the new capabilities, clinicians, for example, will be better able to efficiently identify options for the diagnosis, treatment and monitoring of health conditions such as cancer, stroke and heart disease. Researchers, meanwhile, will gain new insights to aid clinical trial design, monitoring and evaluation, IBM said.

Overall, the combination could better equip providers in radiology, cardiology, orthopedics and ophthalmology to deliver more personalized approaches to the diagnosis, treatment and monitoring of patients, it added.

Late last month IBM partnered with CVS Health with a focus on using predictive analytics to help manage chronic diseases. Its other health-related acquisitions this year have included Phytel and Explorys.


Follow Us

Join the newsletter!

Or

Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

Tags cloud computingMergers and acquisitionsinternetbusiness issuesIBMindustry verticalshealth careSoftware as a service

Featured

Slideshows

Ingram Micro maintains Showcase 2018 momentum in Wellington

Ingram Micro maintains Showcase 2018 momentum in Wellington

Ingram Micro maintained Showcase 2018 momentum in Wellington, hosting more than 40 vendors at TSB Arena. Under the banner of Leading the Way, the event demonstrated what’s new, what’s next and how it can be used to improve business and everyday life.

Ingram Micro maintains Showcase 2018 momentum in Wellington
Ingram Micro launches Showcase 2018 in Christchurch

Ingram Micro launches Showcase 2018 in Christchurch

Ingram Micro kickstarted Showcase 2018 in Christchurch, hosting more than 40 vendors at Horncastle Arena. Under the banner of Leading the Way, the event demonstrated what’s new, what’s next and how it can be used to improve business and everyday life.

Ingram Micro launches Showcase 2018 in Christchurch
Data breach notification laws in NZ: How can partners prepare?

Data breach notification laws in NZ: How can partners prepare?

This exclusive Reseller News Roundtable outlined the responsibilities facing security partners today, assessing risk while evaluating the role of the vendor in providing added layers of protection.

Data breach notification laws in NZ: How can partners prepare?
Show Comments